Kibow Biotech Press Releases

Nov 20, 2017, 07:15 ET

  • Global $10 Billion Probiotics Dietary Supplement Market 2017-2022 – Key Players are DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and Kibow BiotechSome of the key players discussed in the report include DowDuPont, Chr. Hansen Holding A/S, Royal DSM N.V., Cargill. Lifeway Foods, and Kibow Biotech among others. New product launch owing to continuous R&D and industry integrations are the major strategies being adopted by players to differentiate

          Read More →

Oct 31, 2017, 08:35 ET

  • Kibow Biotech’s “Enteric Dialysis®” Technology and Its Renadyl™ Product Formulation for Maintaining Healthy Kidney Function Is to Showcase Its Ultimate Validation at the Annual ASN 2017 – Kidney Week Conference

          Read More →

Oct 24, 2017, 08:40 ET

  • Revolutionary, Non-Invasive, Cost Effective Renal Technology Working 24/7 Shows It Helps Maintain Healthy Kidney Function

    For 20 years, Kibow Biotech has been refining a novel approach to maintaining healthy kidney function “Enteric Dialysis®”. Enteric Dialysis® utilizes probiotics (yes, probiotics) to metabolize the waste products (toxins) building up in the bloodstream due to reduced kidney function. Kibow Biotech will be exhibiting for the 13th consecutive year at the annual American Society of Nephrology conference in New Orleans, Louisiana

          Read More →

Oct 11, 2017, 08:45 ET

  • Kibow Biotech Celebrates 20 Years of Operations With Further Validation of Its “Enteric Dialysis®” Technology, and Renadyl™ Product Formulation for Maintaining Healthy Kidney Function

    Kibow Biotech is proud to announce its twentieth year of operations as a leader in the kidney health supplement marketplace. Nine out of 10 biotech companies fail within the first five years of business; Kibow has managed to stay on the cutting edge of science with its product Renadyl™ based on “Enteric Dialysis®” technology. Renadyl™ is the first and only kidney health supplement formulated to maintain healthy kidney function.

          Read More →

Jun 20, 2017, 08:35 ET

  • Kibow Biotech Inc. (Buzz of Bio Winner, 2014) Receives US Patent for Gout/Hyperuricemia Product Formulation Based on Modulation of the Gut Microbiome With Probiotics and Prebiotics

Kibow Biotech Inc., a pioneer in developing “Enteric Dialysis®” technology, is pleased to                         announce the issuance of a new patent covering a unique method for preventing or treating gout           or hyperuricemia by the U.S. Patent and Trademark Office on May 23rd 2017.

          Read More →

Mar 09, 2017, 08:35 ET

  • Kibow Biotech Inc. to Support the World Kidney Day (March 9th) With an Independent Educational Webinar on “Obesity and Chronic Kidney Disease” and Modulating the “Gut Microbiome With Pro/Prebiotics” Based on Its Novel “Enteric Dialysis®” Technology Formulation

          Read More 

Nov 15, 2016, 08:40 ET

          Read More →

Nov 12, 2015, 08:45 ET

Jun 16, 2015, 08:45 ET

Nov 11, 2014, 08:30 ET

Sep 22, 2014, 08:30 ET

May 07, 2014, 08:30 ET

Apr 15, 2014, 08:30 ET

Mar 14, 2014, 08:45 ET

Mar 13, 2014, 08:35 ET